Brief: Cytrx Corporation Highlights Orphazyme's Announcement Of Its Collaboration With The Michael Fox Foundation On Parkinson's Disease Research
20/07/2020 14:25
July 20 (Reuters) - CytRx Corp CYTR.PK :
* CYTRX CORPORATION HIGHLIGHTS ORPHAZYME'S ANNOUNCEMENT OF
ITS
COLLABORATION WITH THE MICHAEL J. FOX FOUNDATION ON PARKINSON'S
DISEASE RESEARCH
Source text for Eikon: ID:nPnc45MbNa
Further company coverage: CYTR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C